148 related articles for article (PubMed ID: 22429996)
1. Perfluoroalkyl acids: recent research highlights.
Lau C
Reprod Toxicol; 2012 Jul; 33(4):405-409. PubMed ID: 22429996
[No Abstract] [Full Text] [Related]
2. Perfluorinated compounds.
Lau C
Exp Suppl; 2012; 101():47-86. PubMed ID: 22945566
[TBL] [Abstract][Full Text] [Related]
3. [Researching progresses in environmental pollution behavior, toxic effects and mechanisms of PFOS/PFOA].
Zhou QX; Hu XG
Huan Jing Ke Xue; 2007 Oct; 28(10):2153-62. PubMed ID: 18268971
[TBL] [Abstract][Full Text] [Related]
4. Does exposure to perfluoroalkyl acids present a risk to human health?
Rosen MB; Lau C; Corton JC
Toxicol Sci; 2009 Sep; 111(1):1-3. PubMed ID: 19561327
[No Abstract] [Full Text] [Related]
5. Perfluoroalkyl substances in human bone: concentrations in bones and effects on bone cell differentiation.
Koskela A; Koponen J; Lehenkari P; Viluksela M; Korkalainen M; Tuukkanen J
Sci Rep; 2017 Jul; 7(1):6841. PubMed ID: 28754927
[TBL] [Abstract][Full Text] [Related]
6. Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK).
Verner MA; Loccisano AE; Morken NH; Yoon M; Wu H; McDougall R; Maisonet M; Marcus M; Kishi R; Miyashita C; Chen MH; Hsieh WS; Andersen ME; Clewell HJ; Longnecker MP
Environ Health Perspect; 2015 Dec; 123(12):1317-24. PubMed ID: 26008903
[TBL] [Abstract][Full Text] [Related]
7. [Ubiquitous perfluorinated compounds].
Kucharska A; Góralczyk K; Czaja K; Struciński P; Hernik A; Korcz W; Snopczyńiski T; Ludwicki JK
Rocz Panstw Zakl Hig; 2011; 62(2):137-44. PubMed ID: 21980858
[TBL] [Abstract][Full Text] [Related]
8. [Reference values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) in blood plasma].
Kommission "Human-Biomonitoring" des Umweltbundesamtes
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Aug; 52(8):878-85. PubMed ID: 19685022
[No Abstract] [Full Text] [Related]
9. [Perfluorooctane sulfonic acid and perfluorooctanoic acid].
Minoia C; Leoni E; Sottani C; Biamonti G; Signorini S; Imbriani M
G Ital Med Lav Ergon; 2008; 30(4):309-23. PubMed ID: 19344082
[No Abstract] [Full Text] [Related]
10. Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis.
Cui L; Zhou QF; Liao CY; Fu JJ; Jiang GB
Arch Environ Contam Toxicol; 2009 Feb; 56(2):338-49. PubMed ID: 18661093
[TBL] [Abstract][Full Text] [Related]
11. Why is elevation of serum cholesterol associated with exposure to perfluoroalkyl substances (PFAS) in humans? A workshop report on potential mechanisms.
Andersen ME; Hagenbuch B; Apte U; Corton JC; Fletcher T; Lau C; Roth WL; Staels B; Vega GL; Clewell HJ; Longnecker MP
Toxicology; 2021 Jul; 459():152845. PubMed ID: 34246716
[TBL] [Abstract][Full Text] [Related]
12. Interaction effects on uptake and toxicity of perfluoroalkyl substances and cadmium in wheat (Triticum aestivum L.) and rapeseed (Brassica campestris L.) from co-contaminated soil.
Zhao S; Fan Z; Sun L; Zhou T; Xing Y; Liu L
Ecotoxicol Environ Saf; 2017 Mar; 137():194-201. PubMed ID: 27940134
[TBL] [Abstract][Full Text] [Related]
13. Issues raised by the reference doses for perfluorooctane sulfonate and perfluorooctanoic acid.
Dong Z; Bahar MM; Jit J; Kennedy B; Priestly B; Ng J; Lamb D; Liu Y; Duan L; Naidu R
Environ Int; 2017 Aug; 105():86-94. PubMed ID: 28521193
[TBL] [Abstract][Full Text] [Related]
14. Maternal exposure to specific perfluoroalkyl substances is associated with increasing blood glucose in pregnant women.
Uppal JS; Zheng Q; Le XC
J Environ Sci (China); 2018 Jul; 69():1-2. PubMed ID: 29941244
[No Abstract] [Full Text] [Related]
15. Immunomodulatory effects of exposure to polychlorinated biphenyls and perfluoroalkyl acids in East Greenland ringed seals (Pusa hispida).
Levin M; Gebhard E; Jasperse L; Desforges JP; Dietz R; Sonne C; Eulaers I; Covaci A; Bossi R; De Guise S
Environ Res; 2016 Nov; 151():244-250. PubMed ID: 27504872
[TBL] [Abstract][Full Text] [Related]
16. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women.
Zhang S; Tan R; Pan R; Xiong J; Tian Y; Wu J; Chen L
J Clin Endocrinol Metab; 2018 Jul; 103(7):2543-2551. PubMed ID: 29986037
[TBL] [Abstract][Full Text] [Related]
17. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
[TBL] [Abstract][Full Text] [Related]
18. Identification of protein tyrosine phosphatase SHP-2 as a new target of perfluoroalkyl acids in HepG2 cells.
Yang Y; Lv QY; Guo LH; Wan B; Ren XM; Shi YL; Cai YQ
Arch Toxicol; 2017 Apr; 91(4):1697-1707. PubMed ID: 27572461
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cytotoxicity of pentachlorophenol by perfluorooctane sulfonate or perfluorooctanoic acid in HepG2 cells.
Shan G; Ye M; Zhu B; Zhu L
Chemosphere; 2013 Nov; 93(9):2101-7. PubMed ID: 23972907
[TBL] [Abstract][Full Text] [Related]
20. Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: A systematic review of epidemiologic studies.
Ballesteros V; Costa O; Iñiguez C; Fletcher T; Ballester F; Lopez-Espinosa MJ
Environ Int; 2017 Feb; 99():15-28. PubMed ID: 27884404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
